← FDA DRUG APPROVALS

FDA ANDA · ANDA210017

DROSPIRENONE AND ETHINYL ESTRADIOL

Sponsor: JUBILANT CADISTA

APPLICATION
ANDA210017
TYPE
ANDA
ORIGINAL APPROVAL
2018-09-10
LATEST ACTION
2018-09-10
ROUTE
ORAL-28
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

DROSPIRENONE AND ETHINYL ESTRADIOLDiscontinued
DROSPIRENONE 3MG, ETHINYL ESTRADIOL 0.03MG · TABLET · ORAL-28

Approval history

2018-09-10UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →